title: Pharmacology: Discontinuation of bisphosphonates.
authors.forename: N
authors.initials: N
authors.lastname: Malden
authors.forename: S
authors.initials: S
authors.lastname: Loh
mesh_terms: D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000209:etiology*; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D028761:Withholding Treatment
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate